Dr. Kohji Fukatsu has been working at Takeda Pharmaceutical Company, Ltd. (武田薬品)for over 20 years. During his tenure there, he discovered Rozerem®, which is a hypnotic agent (睡眠薬)launched in the U.S. in 2005, and he is now a project leader of a drug discovery program. He joined E-MAX in January 2007 following his productive research days at Takeda San Diego, Inc.(米国現地法人) He likes chatting and sometimes goes to Yakitori restaurants in Juso, Osaka. Driving, basketball and bowling are some of his favorite pastimes. http://www.takeda.co.jp/pdf/usr/default/ar2007j_19_24676_2.pdf
コメント